Diagnosis to dignity: A vision for Alzheimer’s disease in Australia
Diagnosis to dignity: A vision for Alzheimer’s disease in Australia
614,000-773,000
The number of people with Alzheimer’s disease, including both MCI and Alzheimer’s dementia. Predicted to increase to between 1,190,000 and 1,475,000 in 2050
50,000 people
over the age of 60 with Alzheimer’s disease could continue to work with early diagnosis, treatment and support.
Alzheimer’s dementia total costs are expected to grow from $8.1 billion in 2024 to $17 billion in 2050.
62%
of people believe “life is over” after an Alzheimer’s disease diagnosis.
The opportunity for change
Despite the daunting challenge ahead, the emergence of new diagnostic technologies, and disease modifying treatments, along with increasing evidence on prevention, early diagnosis and dementia management, delivers hope for the first time. Embracing this new paradigm alongside the National Dementia Action Plan, anticipated at the end of 2024, and the recently announced new Aged Care Act, Australia has the opportunity to transform how we approach Alzheimer’s disease, making improved quality of life a more attainable goal.
Australians expect and deserve a better and more hopeful future for Alzheimer’s disease, where every aspect of care and support is individually tailored to enhance the experience from diagnosis through to preserving dignity.
References
2. Australian Bureau of Statistics. Population Projections, Australia, 2022 (base) – 2071. Catalogue no. 3222.0 2023; Variant B9. Available from: https://www.abs.gov.au/statistics/people/population/population-projections-australia/2022-base-2071.
3. Evohealth, Alzheimer’s disease modelling. 2024.
4. Alzheimer’s society, Over half of people fear dementia diagnosis, 62 per cent think it means ‘life is over’. 2016.
5. Australian Bureau of Statistics. Causes of Death, Australia. 2024; Available from: https://www.abs.gov.au/statistics/health/causes-death/causes-death-australia/latest-release.
Renae Beardmore
Managing Director, Evohealth
Deanna
Mill
Advisor, Evohealth
James
Taylor
Advisor, Evohealth